The main pillar of business in the consumer market is the clinically well documented, and in the domestic market, well established professional dietary supplement product, Medox®. The product has a patented process, is developed and processed in Biolink Group`s laboratories and processing plant in Norway. Since its launch on the market in 2001, this product has shown steadily increasing acceptance and strong growth in the Norwegian consumer market.

MEDOX® is very well respected among medical researchers, doctors and other competent health related professionals. MEDOX® has turned out to be a fast growing cash cow for the Biolink Group.

Medox® is manly marketed through therapists and other health educated persons, and through pharmacies. The product is recommended by increasingly more doctors. Medox® is so far approved to be marketed in Norway, Sweden and USA.  Medox® is recommended by the heart and lung associations in Norway . It has been on the market since 2001, without documenting any possible side effects.